Prostate cancer drug that can halve death risk to be offered to thousands in England
PositiveWorld Affairs

A groundbreaking development in cancer treatment is here, as thousands of men in England will soon have access to darolutamide, a drug that can significantly reduce the risk of death from advanced prostate cancer. This decision by the National Institute for Health and Care Excellence (NICE) means that at least 6,000 men with hormone-sensitive cancer will benefit from a treatment that not only blocks cancer growth but also comes with fewer side effects compared to existing options. This is a major step forward in improving the quality of life and survival rates for those affected by this disease.
— Curated by the World Pulse Now AI Editorial System










